Results 71 to 80 of about 78,358 (263)

Promoting a culture of respect in cardiothoracic surgery: navigating challenges in understanding unethical behaviour

open access: yesMedičnì Perspektivi
Unprofessional behaviour in the workplace, such as bullying, harassment, and discrimination, remains common in the cardiothoracic surgery unit. Despite its prevalence, there is little consensus on what constitutes unprofessional behaviour in the ...
A.Yu. Sydorenko , H. Spindler
doaj   +1 more source

Open-heart surgery and coronary artery bypass grafting in Western Africa

open access: yesThe Pan African Medical Journal, 2011
We read with concern the paper of Budzee and colleagues in a recent issue of the Pan African Medical Journal. We wish to draw the attention of the authors and the readership of the journal to gross inaccuracies in the report. The first open-heart surgery
Frank Edwin, Kwabena Frimpong-Boateng
doaj   +1 more source

Cardiothoracic surgical emergencies in a Niger Delta Tertiary Health Institution: A 12 month appraisal

open access: yesIbom Medical Journal, 2008
BACKGROUND: Many cardiothoracic surgical emergencies maybe life threatening. More than 70% of these are caused by thoracic trauma. Fortunately about 85% of thoracic trauma may be optimally treated with closed tube thoracostomy drainage (CTTD) or lesser ...
Ekpe EE, Nottidge TE, Akaiso OE
doaj   +1 more source

Inflammatory Cytokines as Early Predictors of Weaning Failure From Extracorporeal Life Support

open access: yesArtificial Organs, EarlyView.
Levels of IL‐8 and IL‐6 and their dynamics are reliable early predictors of ECLS weaning failure. ABSTRACT Background Weaning from extracorporeal life support (ECLS) in patients with refractory shock still remains a complex decision. Despite considerable advances in ECLS management, reliable biomarkers to predict weaning success are still not available.
Kostiantyn Kozakov   +11 more
wiley   +1 more source

Percutaneous Versus Surgical Cannulation for Femoro‐Femoral Venoarterial Extracorporeal Membrane Oxygenation: A Retrospective Cohort Study on Cannulation‐Related Complications

open access: yesArtificial Organs, EarlyView.
Percutaneous femoro‐femoral V‐A ECMO cannulation was associated with more than a two‐fold lower risk of site bleeding and nearly a six‐fold lower risk of infection compared with surgical cut‐down, with no difference in limb ischemia. Absence of distal perfusion catheterization and larger arterial cannula size were additional modifiable ischemia risk ...
Axel Dimberg   +3 more
wiley   +1 more source

A fatal Candida albicans pericarditis presenting with cardiac tamponade after COVID‐19 infection and cardiothoracic surgery [PDF]

open access: gold, 2023
Maryam Salimi   +7 more
openalex   +1 more source

The Impact of Obesity on Durable Left Ventricular Assist Device Implantation: A Systematic Review and Meta‐Analysis

open access: yesArtificial Organs, EarlyView.
14 100 LVAD patients across 21 studies were analyzed. Findings indicated that obese LVAD recipients had lower short‐term mortality and higher risk of infection, thrombosis and right heart failure. There was no difference in long‐term survival between obese and non‐obese patients.
Hugh Jacobs   +11 more
wiley   +1 more source

Driveline Infections Among Patients Supported With Left Ventricular Assist Devices: A Single Center Sixteen‐Year Longitudinal Profile

open access: yesArtificial Organs, EarlyView.
Our study of 1026 LVAD implants revealed HeartWare had lower driveline infection rates than other LVAD types. In addition, severe diabetes was associated with higher risk, while older age and coronary artery disease were linked to a lower risk of driveline infections.
Anh Nguyen   +6 more
wiley   +1 more source

Hemocompatibility and Long‐Term Outcomes in HeartWare Versus HeartMate II Versus HeartMate 3: Multicenter Real‐World Cohort

open access: yesArtificial Organs, EarlyView.
Multicenter real‐world cohort (n = 327) comparing LVADs: HeartMate 3 (HM3), HeartMate II (HMII), and HeartWare (HVAD). HM3 showed superior long‐term survival versus legacy devices, driven by fewer hemocompatibility‐related adverse events, especially pump thrombosis and ischemic stroke, while major bleeding was similar across devices.
Hamza H. H. Ben Nasir   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy